UDD Logo
CRIS - Current Research Information System
New user? Click here to register.Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
  1. Home
  2. CRIS
  3. Publications
  4. Betulinic Acid ω-Triphenylphosphonium Alkyl Esters: Antiproliferative Activities and In Silico Pharmacokinetic Profiles
Details

Betulinic Acid ω-Triphenylphosphonium Alkyl Esters: Antiproliferative Activities and In Silico Pharmacokinetic Profiles

Journal
Biomedicines
ISSN
2227-9059
Date Issued
2025-06-24
Author(s)
SUAREZ ROZAS, CRISTIAN IGNACIO  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Claudia Duarte-Salinas
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Javier Gajardo-De la Fuente
Paola Salgado-Figueroa
Julio Salas-Norambuena
Bruce K. Cassels
Cristina Theoduloz
José A. Jara
Sebastián Fuentes-Retamal
CAMPODONICO GALDAMES, PAOLA ROSSANA  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Jorge Soto-Delgado
Mabel Catalán
Type
journal-article
DOI
10.3390/biomedicines13071539
URL
https://hdl.handle.net/123456789/11318
Abstract
<jats:p>Background: Betulinic acid (BA) and some derivatives are well-known antiproliferative compounds. Literature precedents suggest that incorporating triphenylphosphonium (TPP+) salts on this triterpenoid scaffold enhances its biological activity. In the present study, we carried out a simple synthesis of C-28 ester derivatives of this triterpenoid conjugated with TPP+ bromide salts through 4- to 6-carbon chains via nucleophilic substitution of the corresponding ω-TPP+bromoalkanes. Tests for antiproliferative activity in nine cancer cell lines and normal human fibroblasts showed that TPP+ incorporation enhanced the potency of BA by more than an order of magnitude, up to 100-fold. BA-C4-TPP+Br−, with a four-carbon chain separating the TPP+ moiety from the BA, showed remarkable antiproliferative effects, sometimes more potent than the reference drug (Etoposide). This compound exhibited the strongest mitochondrial uncoupling effect in human cancer cells. No significant LDH release was noted in colorectal carcinoma cells at low micromolar concentrations of BA-C4-TPP+Br−, and sub-micromolar concentrations were sufficient for inducing apoptosis. The in silico prediction of pharmacokinetic properties suggested high oral absorption (88%), as well as a non-inhibitor and non-substrate profile vs. cytochrome isoenzymes. These results point to this compound as a promising lead for the development of novel anticancer drugs.</jats:p>
Cite this document
Suárez-Rozas, C., Duarte-Salinas, C., Gajardo-De La Fuente, J., Salgado-Figueroa, P., Salas-Norambuena, J., Cassels, B. K., Theoduloz, C., Jara, J. A., Fuentes-Retamal, S., Campodónico, P. R., Soto-Delgado, J., & Catalán, M. (2025). Betulinic acid ω-triphenylphosphonium alkyl esters: Antiproliferative activities and in silico pharmacokinetic profiles. Biomedicines, 13(7), 1539. https://doi.org/10.3390/biomedicines13071539
Logo Universidad de Desarrollo
Encuéntranos en:

Sede Santiago

Av. Plaza 680, Las Condes

Contacto|Mapa

Sede Concepción

Ainavillo 456, Concepción

Contacto|Mapa

Hosting & SupportLogo Scimago Lab

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify